1-18871920-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003748.4(ALDH4A1):c.*925C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 152,162 control chromosomes in the GnomAD database, including 4,967 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 4962 hom., cov: 34)
Exomes 𝑓: 0.24 ( 5 hom. )
Consequence
ALDH4A1
NM_003748.4 3_prime_UTR
NM_003748.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.589
Genes affected
ALDH4A1 (HGNC:406): (aldehyde dehydrogenase 4 family member A1) This protein belongs to the aldehyde dehydrogenase family of proteins. This enzyme is a mitochondrial matrix NAD-dependent dehydrogenase which catalyzes the second step of the proline degradation pathway, converting pyrroline-5-carboxylate to glutamate. Deficiency of this enzyme is associated with type II hyperprolinemia, an autosomal recessive disorder characterized by accumulation of delta-1-pyrroline-5-carboxylate (P5C) and proline. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-18871920-G-A is Benign according to our data. Variant chr1-18871920-G-A is described in ClinVar as [Benign]. Clinvar id is 294341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.273 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALDH4A1 | NM_003748.4 | c.*925C>T | 3_prime_UTR_variant | 15/15 | ENST00000375341.8 | ||
ALDH4A1 | NM_001161504.2 | c.*925C>T | 3_prime_UTR_variant | 15/15 | |||
ALDH4A1 | NM_001319218.2 | c.*925C>T | 3_prime_UTR_variant | 14/14 | |||
ALDH4A1 | NM_170726.3 | c.*42-130C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALDH4A1 | ENST00000375341.8 | c.*925C>T | 3_prime_UTR_variant | 15/15 | 1 | NM_003748.4 | P1 | ||
ALDH4A1 | ENST00000538839.5 | c.*925C>T | 3_prime_UTR_variant | 14/14 | 1 | ||||
ALDH4A1 | ENST00000290597.9 | c.*42-130C>T | intron_variant | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.252 AC: 38234AN: 151940Hom.: 4959 Cov.: 34
GnomAD3 genomes
AF:
AC:
38234
AN:
151940
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.240 AC: 25AN: 104Hom.: 5 Cov.: 0 AF XY: 0.263 AC XY: 20AN XY: 76
GnomAD4 exome
AF:
AC:
25
AN:
104
Hom.:
Cov.:
0
AF XY:
AC XY:
20
AN XY:
76
Gnomad4 AFR exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.252 AC: 38260AN: 152058Hom.: 4962 Cov.: 34 AF XY: 0.245 AC XY: 18230AN XY: 74312
GnomAD4 genome
AF:
AC:
38260
AN:
152058
Hom.:
Cov.:
34
AF XY:
AC XY:
18230
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
408
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hyperprolinemia type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at